A doctors' group in California is making the costs of several basic medical services available online. The idea is to compete against less-transparent health care providers. Alisa Roth has the story.
Animal testing in science and medicine has its limits — both ethical and practical. So scientists are working to develop experimentation that's cheaper, faster and, sometimes, more accurate. Janet Babin reports.
GlaxoSmithKline stocks have continued their nosedive following release of a study that links the drugmaker's No. 2 seller to increased risk of heart attacks. But things could turn around. The FDA isn't taking action yet, Stephen Beard reports.
Health officials have discovered an invaluable new spokesperson to get their message out to hard-to-reach populations: the local barber. Beauty salons and barbershops around the country are changing lives. Mhari Saito has the story.
An investigation by a British TV show has set off much debate and a formal inquiry as to whether the wireless Internet access points are emitting unsafe levels of radiation. Skeptics say it's all based on incomplete science, Stephen beard reports.
Why do some pharmaceutical shares tend to experience significant ups and downs just before a doctors' conference? It's not coincidence. Bob Moon reports.
There's a lot of money to be made curing insomnia — about $6 billion last year alone, according to a new report. And that dollar amount is only expected to grow over the next decade. Janet Babin tells us why.
Finding, keeping and affording health insurance is a big headache for small businesses. Steve Tripoli reports on the challenge faced by a company he's been watching for years.
